Delivery Order SPE2DB20D3103-SPE2DB25FN7R7

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Refresh Tears 0.5% eye drops (15 ml). The contract has a ceiling value of $1,773.60 and runs through November 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999, which serves as a primary vehicle for supplying a wide range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Tears 0.5% eye drops. The $1,254.10 firm fixed-price contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is a $2,345.55 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of 0.5% Refresh Tears eye drops in 15ml bottles. The contract has a period of performance through June 14, 2024 and was awarded on June 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,227.39 firm-fixed-price delivery order is for the supply of 0.5% Refresh Tears eye drops in 15 ml bottles. The contract has an ultimate completion date of September 29, 2022 and was awarded on September 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,668.57, is for the delivery of Refresh Tears 0.5% eye drops in 15 mL bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of March 13, 2025. Amerisourcebergen is the prime contractor on this award and does not have any major subcontractors listed. This contract award...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,957.84, is for the delivery of Refresh Tears 0.5% eye drops in 15ml bottles. This is a firm fixed-price delivery order contract with a completion date of July 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for a one-year delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5% Refresh Tears eye drops in 15 ml bottles. The $1,033.98 firm-fixed-price contract does not have a set-aside designation, indicating open competition. This contract is a child order under a larger Indefinite Delivery Contract (IDC) vehicle valued at $999,999,999 held by AmerisourceBergen with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Plus 0.5% eye drops. The contract has a firm fixed price, a ceiling value of $1,014.55, and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,293.36, is a Delivery Order for the supply of REFRESH TEARS 0.5% EYE DROP 15ML. The contract has a firm fixed price pricing type and an ultimate completion date of December 19, 2024. There was no set-aside designation used for this award. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,235.61, is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 10, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN7R7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Refresh Tears 0.5% eye drops in 15 ml bottles, with a firm fixed price of $3,348.60 and a performance period ending on May 12, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is a part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/8/25, 9:58 AM